Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001443-22Phase 4Active
Phase 4, randomised trial of heparin in coronary arteriosclerosis (2 arms), sponsored by Policlinico di Bari. Primary endpoints: Endogenous thrombin potential (ETP) and Plasmatic level of PF1+2. Started Mar 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001443-22.